Another study analyzing different subtypes of breast cancer found that plasma folate levels are lower in patients with human epidermal growth factor receptor 2 (HER2+) and triple-negative cancer [104]; however, more in-depth studies are needed in this area. This evidence concerns the gene ERBB2 and breast cancer.